Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Possible Liabilities of Pyrrole-Containing Drugs

As one could imagine, the highly reactive intermediates from pyrrole could wreak havoc in the physiological system. Nucleophiles such as the thiol group could induce toxicities. As a result, the development of mopidralazine was subsequently discontinued. [Pg.47]

Similar oxidative metabolism was observed for premazepam, an antianxiety drug, in the rat and the dog prinomide, an anti-inflammatory agent, in six i ecies of laboratory animals and pyrrolnitrin, an anti-fungal agent, in rats.  [Pg.47]

Nonetheless, if one assumes that all pyrrole-containing drugs are toxic, we would have missed atorvastatin (Lipitor). Atorvastatin is remarkably safe barring the mechanism-based safety concerns such as rhabdomyolysis that are associated with all HMG-CoA inhibitors. Although atorvastatin contains the pyrrole ring, it has at least three factors that strongly attenuate its nucleophilicity. First, it is fully substituted at all [Pg.47]

In drug discovery, as in many other things in life, there are always exceptions to the rules. Frequently, the safety and efficacy of a drug can only be determined by clinical trials as the touchstone. [Pg.48]

1 Explain why the dipole moments for pyrrole and pyrrolidine have the opposite directions  [Pg.49]


See other pages where Possible Liabilities of Pyrrole-Containing Drugs is mentioned: [Pg.46]   


SEARCH



Liability

Of pyrrole

Pyrrole-containing drugs

© 2024 chempedia.info